[go: up one dir, main page]

NO20023752D0 - 2-carboxamide benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury - Google Patents

2-carboxamide benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury

Info

Publication number
NO20023752D0
NO20023752D0 NO20023752A NO20023752A NO20023752D0 NO 20023752 D0 NO20023752 D0 NO 20023752D0 NO 20023752 A NO20023752 A NO 20023752A NO 20023752 A NO20023752 A NO 20023752A NO 20023752 D0 NO20023752 D0 NO 20023752D0
Authority
NO
Norway
Prior art keywords
carboxamide
prevention
treatment
reperfusion injury
ischemic reperfusion
Prior art date
Application number
NO20023752A
Other languages
Norwegian (no)
Other versions
NO20023752L (en
Inventor
Nicholas Nikolaides
Donatella Chianelli
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20023752D0 publication Critical patent/NO20023752D0/en
Publication of NO20023752L publication Critical patent/NO20023752L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20023752A 2000-02-09 2002-08-08 2-carboxamide benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury NO20023752L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18123400P 2000-02-09 2000-02-09
PCT/US2001/004211 WO2001058878A1 (en) 2000-02-09 2001-02-08 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury

Publications (2)

Publication Number Publication Date
NO20023752D0 true NO20023752D0 (en) 2002-08-08
NO20023752L NO20023752L (en) 2002-10-09

Family

ID=22663432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023752A NO20023752L (en) 2000-02-09 2002-08-08 2-carboxamide benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury

Country Status (7)

Country Link
EP (1) EP1263736A1 (en)
JP (1) JP2003522759A (en)
AU (1) AU2001236821A1 (en)
CA (1) CA2399795A1 (en)
IL (1) IL150525A0 (en)
NO (1) NO20023752L (en)
WO (1) WO2001058878A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
CN108456171B (en) * 2018-03-16 2021-07-27 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） A FLT3/ITD mutant inhibitor and its application in the prevention and treatment of tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002517396A (en) * 1998-06-04 2002-06-18 アボット・ラボラトリーズ Anti-inflammatory compounds that inhibit cell adhesion

Also Published As

Publication number Publication date
JP2003522759A (en) 2003-07-29
AU2001236821A1 (en) 2001-08-20
NO20023752L (en) 2002-10-09
WO2001058878A1 (en) 2001-08-16
IL150525A0 (en) 2003-02-12
EP1263736A1 (en) 2002-12-11
CA2399795A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
NO20032695L (en) Carboxamide derivatives and their use in the treatment of thromboembolic diseases
NO20034169L (en) MCH antagonists and their use in the treatment of obesity
NO20022680L (en) Pharmaceutical combinations and their use in the treatment of gastrointestinal disorders
DE60131644D1 (en) INFRARED THERMOGRAPHY AND TREATMENT OF SEXUAL DYSFUNCTIONS
IS2971B (en) Freeze-dried pantoprazole mixture and pantoprazole injection
DE50112013D1 (en) DEODORANTIA AND ANTIPERSPIRANTIES
DE60128441D1 (en) REAL TREATMENT AND MANUFACTURING PROCESS
FI20002429L (en) Blow-on drying unit and drying section
NO20023566D0 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity
DE60019490D1 (en) Fuel conveyor and treatment device
NO20016149D0 (en) Indole derivatives and their use in the treatment of cheese porosis among other applications
IS5280A (en) Compositions for the treatment and prevention of arterial thromboembolism and the use of components Xa lata alone and / or in combination with antiplatelet agents
DE60143999D1 (en) Printing device and printing process
NO20031851D0 (en) Combination of fenofibrate and coenzyme Q 10 for the treatment of endothelial malfunction
NO20025307L (en) Use of IL-18 inhibitors for the treatment and / or prevention of atherosclerosis
NO20033498D0 (en) Process for the treatment and drying of wood
NO20041214L (en) Substituted benzimidazole compounds and their use in the treatment of cancer
NO20030034D0 (en) A combination of FBPase inhibitors and antidiabetic agents useful in the treatment of diabetes
FI20001832A0 (en) In the treatment and prevention of chlamydia infection effective vegetable phenol compounds and sulfur compounds
ATE285942T1 (en) FILM TREATMENT APPARATUS AND WRAP APPARATUS
DE60102323D1 (en) Surface treatment agent and water and oil repellent article
NO20020031D0 (en) Dihydrobenzodiazepines and their use in the treatment of dyslipidemia
DE60030642D1 (en) Wet treatment nozzle, nozzle device and wet treatment device
DE50112505D1 (en) Wastewater treatment plant and warping process
NO20023752D0 (en) 2-carboxamide benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application